It stops the body being told to produce an enzyme known to play a key role in coronavirus and other respiratory infections, enabling the virus to enter host cells and proliferate
I’m Paul Hutton with news that a new inhaler therapy that alters genetic data in the lungs to stop coronavirus taking hold is being developed. The Telegraph reports the treatment works by sending nanoparticles into the lungs containing tiny molecular scissors that snip away genetic messages. It stops the body being told to produce an enzyme known to play a key role in coronavirus and other respiratory infections, enabling the virus to enter host cells and proliferate. For more care related stories stay with us here at Care Radio.
Archbishop calls for society wide shift in support for unpaid carers
Young Carers missing out on carer's allowance
20% increase in those at risk from type 2 diabetes
Black and ethnic minority people are underrepresented in virtual patient cohorts.
NHS dental treatment has still not returned to pre-pandemic levels
London councils object to relocation of specialist cancer service
West Lothian Council workers could trigger a summer of strike action
Care UK in Portsmouth to remember the hundreds of thousands of those who took part in D-Day
NHS and social care leaders could save £1 billion annually by adopting an AI-led home healthcare model
Software to reduce hospital waiting times will be rolled out across Scotland over the next year
No money for carers to get free public transport in Suffolk
Carer's Allowance overpayments affecting five thousand people in Northern Ireland
Information about insect bites and stings surges ahead of this bank holiday weekend
Skinny jabs like Ozempic are being used as a cop-out